Monday, July 22, 2013

Targeted approach. The reality

Interesting reading from here:

"Cancer researchers and doctors all over the world are getting increasingly excited about the new era of molecular therapies designed to target specific gene faults in tumours. But while these drugs tend to show impressive results, their effectiveness soon wanes and the cancer comes back after a number of months or years, as it evolves resistance to the therapy."

No comments:

Post a Comment